Company behind satiety pill is looking for partners
A Danish CRO company, which has already received millions from The Danish National Advanced Technology Foundation for the development of a so-called satiety pill, is expected to form a Big Pharma-partnership in the near future.
af LEONORA BECK
“We began the project initially, we are running the project, and then we have teamed up with skilled researchers from the University of Copenhagen and Gentofte Hospital,” says co-founder and CEO in the CRO company Gubra, Niels Vrang, about the project described here on Medwatch last week.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Millions for the search of satiety pill
For abonnenter
